NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 160 filers reported holding NEVRO CORP in Q1 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $53,912 | +176.5% | 2,805 | +265.7% | 0.00% | – |
Q2 2023 | $19,497 | +10.3% | 767 | +56.9% | 0.00% | – |
Q1 2023 | $17,677 | +4.0% | 489 | +36.6% | 0.00% | – |
Q3 2022 | $17,000 | -22.7% | 358 | -29.4% | 0.00% | – |
Q2 2022 | $22,000 | +144.4% | 507 | +305.6% | 0.00% | – |
Q1 2022 | $9,000 | -40.0% | 125 | -35.9% | 0.00% | – |
Q4 2021 | $15,000 | +1400.0% | 195 | +3150.0% | 0.00% | – |
Q4 2020 | $1,000 | – | 6 | +500.0% | 0.00% | – |
Q2 2020 | $0 | – | 1 | 0.0% | 0.00% | – |
Q1 2020 | $0 | -100.0% | 1 | -96.0% | 0.00% | – |
Q4 2019 | $3,000 | +50.0% | 25 | 0.0% | 0.00% | – |
Q3 2019 | $2,000 | -83.3% | 25 | -86.6% | 0.00% | – |
Q2 2019 | $12,000 | -61.3% | 186 | -63.3% | 0.00% | – |
Q1 2019 | $31,000 | -3.1% | 507 | -38.5% | 0.00% | – |
Q4 2018 | $32,000 | -86.2% | 825 | -79.8% | 0.00% | -100.0% |
Q3 2018 | $232,000 | -48.1% | 4,080 | -27.2% | 0.00% | 0.0% |
Q2 2018 | $447,000 | -0.4% | 5,601 | +8.2% | 0.00% | 0.0% |
Q1 2018 | $449,000 | +43.5% | 5,176 | +14.3% | 0.00% | 0.0% |
Q4 2017 | $313,000 | -12.8% | 4,530 | +14.7% | 0.00% | 0.0% |
Q3 2017 | $359,000 | +85.1% | 3,951 | +51.5% | 0.00% | 0.0% |
Q2 2017 | $194,000 | +304.2% | 2,608 | +412.4% | 0.00% | – |
Q1 2017 | $48,000 | +220.0% | 509 | +147.1% | 0.00% | – |
Q4 2016 | $15,000 | -28.6% | 206 | +2.5% | 0.00% | – |
Q3 2016 | $21,000 | -64.4% | 201 | -75.1% | 0.00% | – |
Q2 2016 | $59,000 | +353.8% | 806 | +258.2% | 0.00% | – |
Q1 2016 | $13,000 | -13.3% | 225 | 0.0% | 0.00% | – |
Q4 2015 | $15,000 | – | 225 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tiger Eye Capital LLC | 239,122 | $41,392,000 | 8.25% |
Integral Health Asset Management, LLC | 88,000 | $15,233,000 | 4.53% |
Iron Triangle Partners LP | 168,761 | $29,213,000 | 3.79% |
Eos Focused Equity Management, L.P. | 14,002 | $2,424,000 | 2.37% |
PFM Health Sciences, LP | 311,940 | $53,997,000 | 1.90% |
Perceptive Advisors | 977,565 | $169,217,000 | 1.82% |
Rock Springs Capital Management LP | 395,000 | $68,375,000 | 1.45% |
Lisanti Capital Growth, LLC | 54,302 | $9,400,000 | 1.30% |
HealthCor Management, L.P. | 156,046 | $27,012,000 | 1.04% |
FRED ALGER MANAGEMENT, LLC | 2,136,612 | $369,848,000 | 0.96% |